BRCA1 and neoplasm: In addition, we also observed ART558 sensitivity in an ex vivo cultured tumour organoid derived from a BRCA1-mutant breast cancer, KCL014BCPO, but not in a BRCA1 wild type breast cancer organoid cultured under similar conditions (Fig. 3d, e).